نتائج البحث - Sivakumar Periasamy

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Programmed Death 1 and Cytokine Inducible SH2-Containing Protein Dependent Expansion of Regulatory T Cells Upon Stimulation With Mycobacterium tuberculosis

    Programmed Death 1 and Cytokine Inducible SH2-Containing Protein Dependent Expansion of Regulatory T Cells Upon Stimulation With Mycobacterium tuberculosis حسب Sivakumar Periasamy, Rohan Dhiman, Peter F. Barnes, Padmaja Paidipally, Amy Tvinnereim, Anuradha Bandaru, Vijaya Lakshmi Valluri, Ramakrishna Vankayalapati

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    NK1.1+ Cells and IL-22 Regulate Vaccine-Induced Protective Immunity against Challenge with <i>Mycobacterium tuberculosis</i>

    NK1.1+ Cells and IL-22 Regulate Vaccine-Induced Protective Immunity against Challenge with <i>Mycobacterium tuberculosis</i> حسب Rohan Dhiman, Sivakumar Periasamy, Peter F. Barnes, Ankita Garg Jaiswal, Padmaja Paidipally, Amanda B. Barnes, Amy Tvinnereim, Ramakrishna Vankayalapati

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Antibody effector functions are associated with protection from respiratory syncytial virus

    Antibody effector functions are associated with protection from respiratory syncytial virus حسب Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Tomer Zohar, Sivakumar Periasamy, Nickita Mehta, Jeroen Tolboom, Leslie van der Fits, Jerry Sadoff, Christy Comeaux, Benoît Callendret, Alexander Bukreyev, Douglas A. Lauffenburger, Arangassery Rosemary Bastian, Galit Alter

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2

    Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2 حسب Douglas F. Lake, Alexa J. Roeder, Erin Kaleta, Paniz Jasbi, Kirsten Pfeffer, Calvin Koelbela, Sivakumar Periasamy, Natalia A. Kuzmina, Alexander Bukreyev, Thomas E. Grys, Liang Wu, John R. Mills, Kathrine McAulay, María J. González‐Moa, Alim S. Seit‐Nebi, Sergei Svarovsky

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking

    Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking حسب Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Steven C. Wall, Naveenchandra Suryadevara, Daniel Wrapp, Sivakumar Periasamy, Kelsey A. Pilewski, Nagarajan Raju, Rachel S. Nargi, Rachel E. Sutton, Lauren Walker, Ian Setliff, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions

    A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions حسب Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, Sivakumar Periasamy, Chaitanya Kurhade, Jessica A. Plante, Nathen E. Bopp, Birte Kalveram, Alexander Bukreyev, Ping Ren, Tian Wang, Vineet D. Menachery, Kenneth S. Plante, Xuping Xie, Scott C. Weaver, Pei‐Yong Shi

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19

    Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19 حسب Alessandra Soares‐Schanoski, Natalie Sauerwald, Carl Goforth, Sivakumar Periasamy, Dawn L. Weir, Stephen E. Lizewski, Rhonda A. Lizewski, Yongchao Ge, Natalia A. Kuzmina, Venugopalan D. Nair, Sindhu Vangeti, Nada Marjanović, Antonio Cappuccio, Wan Sze Cheng, Sagie Mofsowitz, Clare Miller, Xuechen Yu, Mary‐Catherine George, Elena Zaslavsky, Alexander Bukreyev, Olga G. Troyanskaya, Stuart C. Sealfon, Andrew G. Letizia, Irene Ramos

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

    A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2 حسب Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, Wen‐Jiun Peng, Juin-Hua Huang, Be-Shen Kuo, Lin Feng, Yaw-Jen Liu, Zhi Liu, Huang-Ting Wu, Shuang Ding, Kou-Liang Hou, Jennifer Cheng, Ya-Ting Yang, Ming-Han Jiang, Min-Sheng Wang, Tony Chen, Wei Xia, Ed Lin, Chung Ho Hung, Hui-Jung Chen, Zhonghao Shih, Yi‐Ling Lin, Valorie Ryan, Mei Mei Hu, D. Gray Heppner, Delphine C. Malherbe, Sivakumar Periasamy, Natalia A. Kuzmina, Chandru Subramani, Michael Hellerstein, Thomas P. Monath, Alexander Rumyantsev, Alexander Bukreyev, Farshad Guirakhoo

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: